213 related articles for article (PubMed ID: 31693665)
1. Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine.
Hu R; Golder S; Yang G; Li X; Wang D; Wang L; Xia R; Zhao N; Fang S; Lai B; Liu J; Fei Y
PLoS One; 2019; 14(11):e0222077. PubMed ID: 31693665
[TBL] [Abstract][Full Text] [Related]
2. Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab.
Smith K; Golder S; Sarker A; Loke Y; O'Connor K; Gonzalez-Hernandez G
Drug Saf; 2018 Dec; 41(12):1397-1410. PubMed ID: 30167992
[TBL] [Abstract][Full Text] [Related]
3. [Systematic review on safety of Xinyuan capsules].
Wang JD; Xie YM; Liao X; Cui RZ
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(9):1744-1753. PubMed ID: 28891628
[TBL] [Abstract][Full Text] [Related]
4. Adverse events to Houttuynia injection: A systematic review.
Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.
Niu R; Chen Y; Xiang Y; Liu Y; Guo J; Feng B
Biol Pharm Bull; 2020; 43(10):1476-1480. PubMed ID: 32999157
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.
Luo H; Li Q; Flower A; Lewith G; Liu J
J Ethnopharmacol; 2012 Apr; 140(3):555-67. PubMed ID: 22343092
[TBL] [Abstract][Full Text] [Related]
8. [Systematic review of Kudiezi injection drug safety].
Gao SS; Cui RZ; Xie YM; Liao X; Gao XY; Wang JD
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2380-2390. PubMed ID: 28822197
[TBL] [Abstract][Full Text] [Related]
9. [Differential analysis of different study types in clinical safety evaluation of Xuebijing Injection].
Li Q; Jin XY; Zhou X; Pang WT; Wang KY; Li N; Zheng WK
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):712-721. PubMed ID: 33645039
[TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Li X; Yang G; Liu JP
Cochrane Database Syst Rev; 2013 Oct; (10):CD007796. PubMed ID: 24096743
[TBL] [Abstract][Full Text] [Related]
11. [Adverse drug reactions or adverse events of Chaihu Injection: a systematic review].
Kong XY; Hao Y; Wu TX; Xie YM
Zhong Xi Yi Jie He Xue Bao; 2010 Dec; 8(12):1124-32. PubMed ID: 21144455
[TBL] [Abstract][Full Text] [Related]
12. Social Media Analytics for Pharmacovigilance of Antiepileptic Drugs.
Yahya AA; Asiri Y; Alyami I
Comput Math Methods Med; 2022; 2022():8965280. PubMed ID: 35027943
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Liu JP
Cochrane Database Syst Rev; 2011 Jun; (6):CD007796. PubMed ID: 21678369
[TBL] [Abstract][Full Text] [Related]
14. [Post-marketing surveillance on Guizhi Fuling Jiaonang based on literature review].
Wang GQ; Gao Y; Liu FM; Wei RL; Xie YM
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):820-832. PubMed ID: 29600661
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis.
Lavertu A; Hamamsy T; Altman RB
J Med Internet Res; 2021 Oct; 23(10):e27714. PubMed ID: 34673524
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions of Shuanghuanglian injection: a systematic review of public literatures.
Wang L; Cheng L; Yuan Q; Cui X; Shang H; Zhang B; Li Y
J Evid Based Med; 2010 Feb; 3(1):18-26. PubMed ID: 21349036
[TBL] [Abstract][Full Text] [Related]
17. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
18. Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review.
Tricco AC; Zarin W; Lillie E; Jeblee S; Warren R; Khan PA; Robson R; Pham B; Hirst G; Straus SE
BMC Med Inform Decis Mak; 2018 Jun; 18(1):38. PubMed ID: 29898743
[TBL] [Abstract][Full Text] [Related]
19. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
20. A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database.
Yang H; Wan Z; Chen M; Zhang X; Cui W; Zhao B
Expert Opin Drug Metab Toxicol; 2023 Apr; 19(4):217-223. PubMed ID: 37243615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
